Executive Summary

Oct 2019
PROSPECTS
Switch to disposable nappies/diapers and rising purchasing power ensure growth

Nappy (diaper) rash treatments recorded strong current value growth in dermatologicals in 2019. This was associated with the high birth rate, as well as rising consumer purchasing power, which significantly influenced sales of disposable nappies/diapers.

High unit prices as both local and imported brands are affected by devaluation

The recent devaluation of the local currency against the US dollar made it expensive for consumers to buy imported products, and most dermatologicals are imported. This, along with government support for local companies, should have created more incentive and opportunities to local producers to manufacture domestic consumer health products in the country.

Rise in fungal infections leads to strong growth for topical antifungals

Skin fungal infections are amongst the most frequent dermatological complaints suffered by consumers in Uzbekistan, and seem to be occurring with greater frequency. The warm, clammy summer weather provides the perfect conditions for fungal infections such as athlete’s foot.

COMPETITIVE LANDSCAPE
Multinationals lead dermatologicals due to strong brand reputation

GSK Consumer Healthcare and Johnson & Johnson ranked first and second in dermatologicals respectively in value terms in 2019. GSK Consumer Healthcare’s wide portfolio of brands benefits from a strong and wide distribution network, with the company’s Lamisil brand remaining the leading brand in topical antifungals in 2019, and other strong brands including Zovirax in cold sore treatments and Fenistil in topical allergy remedies/antihistamines.

Domestic company Radiks ranks third, thanks to wide availability and low prices

The Uzbekistani company Radiks ranked third in dermatologicals in value terms in 2019, as the company supplies consumers with boric ointment and spiritus salicylowy, which are widely available in chemists/pharmacies and have accessible prices. In general, local consumers do not look for specific brands when they buy dermatologicals.

Foreign companies lead vaginal antifungals despite challenge from smaller players

French company Servier (via Egis Slovakia) and Canadian company Bausch Health Cos were the only two major players present in vaginal antifungals in 2019, with Servier’s Betadine brand leading by far. Despite its outright lead, sales of Betadine continued to grow in 2019, outpacing Gynalgin by Bausch Health Cos, which saw a sales decline.

Want to find out more about this report?
Request more information
Why buy this report?

Gain competitive intelligence about market leaders. Track key industry trends, opportunities and threats. Inform your marketing, brand, strategy and market development, sales and supply functions.

Your Recently Viewed Reports

Dermatologicals in Uzbekistan

Samples (FAQs about samples):

Delivery: Files are delivered directly into your account within a few minutes of purchase.

Overview

Discover the latest market trends and uncover sources of future market growth for the Medicated Skin Care industry in Uzbekistan with research from Euromonitor's team of in-country analysts.

Find hidden opportunities in the most current research data available, understand competitive threats with our detailed market analysis, and plan your corporate strategy with our expert qualitative analysis and growth projections.

If you're in the Medicated Skin Care industry in Uzbekistan, our research will save you time and money while empowering you to make informed, profitable decisions.

The Medicated Skin Care in Uzbekistan market research report includes:

  • Analysis of key supply-side and demand trends
  • Detailed segmentation of international and local products
  • Historic volumes and values, company and brand market shares
  • Five year forecasts of market trends and market growth
  • Robust and transparent market research methodology, conducted in-country

Our market research reports answer questions such as:

  • What is the market size of Medicated Skin Care in Uzbekistan?
  • What are the major brands in Uzbekistan?
  • What are the most popular formats for acne treatments?

Why buy this report?

  • Gain competitive intelligence about market leaders
  • Track key industry trends, opportunities and threats
  • Inform your marketing, brand, strategy and market development, sales and supply functions

This industry report originates from Passport, our Consumer Health market research database.

Dermatologicals in Uzbekistan - Category analysis

HEADLINES

PROSPECTS

Switch to disposable nappies/diapers and rising purchasing power ensure growth
High unit prices as both local and imported brands are affected by devaluation
Rise in fungal infections leads to strong growth for topical antifungals

COMPETITIVE LANDSCAPE

Multinationals lead dermatologicals due to strong brand reputation
Domestic company Radiks ranks third, thanks to wide availability and low prices
Foreign companies lead vaginal antifungals despite challenge from smaller players

CATEGORY DATA

Table 1 Sales of Dermatologicals by Category: Value 2014-2019
Table 2 Sales of Dermatologicals by Category: % Value Growth 2014-2019
Table 3 NBO Company Shares of Dermatologicals: % Value 2015-2019
Table 4 LBN Brand Shares of Dermatologicals: % Value 2016-2019
Table 5 Forecast Sales of Dermatologicals by Category: Value 2019-2024
Table 6 Forecast Sales of Dermatologicals by Category: % Value Growth 2019-2024

Consumer Health in Uzbekistan - Industry Overview

EXECUTIVE SUMMARY

Strong value growth continues, although volume growth suffers in some categories
Government increases its control, to provide cost-effective, high-quality products
International players continue to lead despite higher local production
Regulations limit the sale of consumer health products to chemists/pharmacies
Continued growth, but more development needed

MARKET INDICATORS

Table 7 Consumer Expenditure on Health Goods and Medical Services: Value 2014-2019
Table 8 Life Expectancy at Birth 2014-2019

MARKET DATA

Table 9 Sales of Consumer Health by Category: Value 2014-2019
Table 10 Sales of Consumer Health by Category: % Value Growth 2014-2019
Table 11 NBO Company Shares of Consumer Health: % Value 2015-2019
Table 12 LBN Brand Shares of Consumer Health: % Value 2016-2019
Table 13 Distribution of Consumer Health by Format: % Value 2014-2019
Table 14 Distribution of Consumer Health by Format and Category: % Value 2019
Table 15 Forecast Sales of Consumer Health by Category: Value 2019-2024
Table 16 Forecast Sales of Consumer Health by Category: % Value Growth 2019-2024

APPENDIX

OTC registration and classification
Vitamins and dietary supplements registration and classification
Self-medication/self-care and preventive medicine
Switches

DEFINITIONS

SOURCES

Summary 1 Research Sources